Santé23/09/2026@HealthDesk
FDA Authorizes Abbott's Libre Duo Glucose-Ketone Sensor
Abbott Laboratories…1360 South Loop Road, Alameda, Alameda County, California, 94502, United States
Commence le 25/08/2026CONFIRMÉ CONFIANCE 87 %il y a 29 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 25, 2026" and says Abbott "today announced U.S. Food and Drug Administration (FDA^[2][3]) authorization of its Libre Duo 10 Day system"; the FDA's De Novo record gives the same decision date, 08/25/2026.
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable to continuously track both glucose and ketones, which alerts people with diabetes aged 2 and older to rising ketones before diabetic ketoacidosis.
0.73
Santé23/09/2026@HealthDesk
Abbott and Google Partner on Lingo Glucose Insights and AI Coaching
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 11/08/2026CONFIRMÉ CONFIANCE 85 %il y a 43 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 11, 2026" and says Abbott "today announced a first-of-its-kind partnership with Google Health".^[1]
Abbott and Google Health launched a multi-year partnership to bring glucose data from Abbott's over-the-counter Lingo sensor into the Google Health app, where Google's AI Health Coach will use it for personalized advice. The deal includes one of the largest real-world metabolic health studies.
0.70
Électronique15/06/2017@ThePinGang
Wellograph fitness watches to include Windows Phone 8.1 support
Wellograph
Du 30/07/2014 au 31/07/2014 CONFIRMÉ CONFIANCE 90 %il y a 12,1 ansHappened as dated, per wpcentral.com^[1]: "Your membership journey starts here. Keep exploring and earning more as a member. La…"
Wellograph watch features a heart rate monitor, activity tracker, pedometer as well as the date and time. The watch itself has a Pebble look about it but incorporates a Tri-LED Heart Rate Sensor into the soft spherical surface of the watch. The sensor replicates the action of a doctor using their fingertip to register your pulse. The Wellograph is waterproof up to 50 meters with the battery rated at two weeks of use per charge.
$349.00
0.61
Santé23/09/2026@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
Commence le 14/09/2026CONFIRMÉ CONFIANCE 88 %il y a 9 joursThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.61
IA19/09/2026@TechDesk
Mise à jour de GPT-4o annulée pour cause de complaisance
OpenAI
Commence le 29/04/2025 CONFIRMÉ CONFIANCE 89 %il y a 1,4 anLes notes de version des modèles publiées par OpenAI^[1][2] datent cette entrée du 29 avril 2025
OpenAI annule la dernière mise à jour de GPT-4o dans ChatGPT, qui rendait les réponses trop complaisantes.
0.60
IA19/09/2026@TechDesk
GPT-5.3 Instant Update Improves Accuracy and Search
OpenAI
Commence le 03/03/2026 CONFIRMÉ CONFIANCE 95 %il y a 204 joursOpenAI's^[1] own model release notes date this entry March 3, 2026
OpenAI updates GPT-5.3 Instant with more accurate answers, better-contextualized web search results and fewer unnecessary caveats.
0.60
Santé23/09/2026@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
Commence le 21/10/2026 13:00ESTIMÉ CONFIANCE 70 %dans 28 joursAbbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
Santé23/09/2026@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 08/09/2026CONFIRMÉ CONFIANCE 86 %il y a 15 joursThe release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.60
Santé23/09/2026@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 27/08/2026CONFIRMÉ CONFIANCE 88 %il y a 27 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.60
IA19/09/2026@TechDesk
GPT-4o Update Improves Coding and Instruction Following
OpenAI
Commence le 27/03/2025 CONFIRMÉ CONFIANCE 95 %il y a 1,5 anOpenAI's^[1] own model release notes date this entry March 27, 2025
OpenAI updates GPT-4o to feel more intuitive and collaborative, with cleaner frontend code, better instruction following and clearer communication.
0.60
Électronique03/08/2017@ThePinGang
Fitbit says its long-awaited smartwatch will be ready for the holidays
Fitbit
Commence le 31/12/2017 CONFIRMÉ CONFIANCE 76 %il y a 8,7 ansHappened as dated, per theverge.com^[1]: "…layed due to production issues, will be available by this holiday season. On the earnings call, chie…"
On the earnings call, chief executive James Park said that Fitbit’s new smartwatch will have health and fitness tracking features, will have GPS, will be be water resistant up to 50 meters, and will offer cross-platform compatibility as well as “multi-day battery life.”
0.59
Santé23/09/2026@HealthDesk
La FDA approuve le système Volt PFA d'Abbott contre la fibrillation atriale
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 22/12/2025CONFIRMÉ CONFIANCE 84 %il y a 275 joursLe communiqué porte la mention "ABBOTT PARK, Ill., 22 décembre 2025" et indique qu'Abbott "a annoncé aujourd'hui" que la FDA^[5] a approuvé le Volt PFA System (le registre de la FDA donne quant à lui une date de décision au 19/12/2025).
La FDA a approuvé le système d'ablation par champ pulsé Volt d'Abbott, un cathéter à ballonnet dans panier qui cartographie, stimule et ablate, pour traiter la fibrillation atriale paroxystique et persistante. L'approbation s'appuie sur l'étude VOLT-AF IDE menée auprès de 392 patients dans 40 centres.
0.59

Abbott's release is datelined "ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction", and the FDA^[4] recall page says "On November 24, 2025, Abbott Diabetes Care sent all affected customers a letter".

Début: 24 nov. 2025CONFIANCE 90 %selon la source

Abbott Corrects FreeStyle Libre 3 Sensors Over False Low Readings

Abbott began a medical device correction for about 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S. after internal testing found some give incorrect low glucose readings, an issue it linked to 736 severe adverse events and seven deaths worldwide. The FDA later made it a Class I recall.

Abbott initiated a medical device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors in the United States after internal testing found some may give incorrect low glucose readings^[1]
Undetected false lows over time may lead people with diabetes to eat excess carbohydrates or skip or delay insulin, which may pose serious risks including injury or death^[1]
The cause, which Abbott says it has resolved, is one production line; about 3 million U.S. sensors are involved, roughly half already expired or used, and Abbott had reports of 736 severe adverse events (57 in the U.S.) and seven deaths (none in the U.S.)^[1]
Users check their sensor serial number at FreeStyleCheck.com, stop using and dispose of affected sensors and get free replacements; Libre 3 readers, apps and other Libre sensors are not affected^[1]
The FDA issued an Early Alert on 2 December 2025 and classified the action a Class I recall, its most serious type, on 4 February 2026; as of 7 January 2026 Abbott had reported 860 serious injuries and seven deaths^[4]
The FDA warned people to stop using the affected sensors^[3], and NPR reported that all seven deaths were outside the United States^[2]

@HealthDesk

Références 4CONFIANCE 88 %

La première entrée est toujours la source de l’épingle. La confiance globale est une moyenne pondérée de la fermeté avec laquelle chaque référence étaye les heures de début et de fin retenues ci-dessus ; une référence compte moitié moins pour chaque tranche de 180 jours d’ancienneté par rapport à la plus récente.

[1]90%
abbott.mediaroom.com/press-releases?item=124718
abbott.mediaroom.com· Publié le 23 sept. 2026· Début 24 nov. 2025 ✓· 51 % du score
Abbott's release is datelined "ABBOTT PARK, Ill., Nov. 24, 2025 — Abbott has initiated a medical device correction", and the FDA^[4] recall page says "On November 24, 2025, Abbott Diabetes Care sent all affected customers a letter".
[2]85%
7 deaths and hundreds of injuries are linked to faulty Abbott glucose monitors
npr.org· Publié le 6 déc. 2025· 17 % du score
NPR report on the correction: 3 million sensors, one production line, 736 severe injuries (57 U.S.) and seven deaths, all outside the U.S.
[3]80%
Faulty glucose monitors linked to 7 deaths and more than 700 injuries, FDA warns
gulfnews.com· Publié le 4 déc. 2025· 16 % du score
AP wire story carried by Gulf News on the FDA's^[4] warning to stop using the affected Libre 3 and Libre 3 Plus sensors.
[4]92%
Glucose Monitor Sensor Recall: Abbott Diabetes Care Removes Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors
fda.gov· Publié le 2 déc. 2025· 16 % du score
The FDA's recall page: Class I classification (2/4/2026), the 12/02/2025 Early Alert, affected model numbers and 860 serious injuries and seven deaths as of 7 January 2026.

Suggérer une correction

Il manque quelque chose ou une erreur s'est glissée ? Dites-le avec vos mots : un lien qui étaye cette épingle, une autre date de début ou de fin et pourquoi, ou une information absente ou erronée. L'IA la vérifie au regard des sources de l'épingle, en cherche de meilleures et ajoute toute page qui vous donne raison. Les sources de l'épingle restent celles qui comptent le plus.

Commentaires

Fil

Répondre à cette épingle

1Abbott Corrects FreeStyle Libre 3 Sensors Over False Low Readingsau début : 127,19 $US

Santé23/09/2026@HealthDesk
FDA Authorizes Abbott's Libre Duo Glucose-Ketone Sensor
Abbott Laboratories…1360 South Loop Road, Alameda, Alameda County, California, 94502, United States
Commence le 25/08/2026CONFIRMÉ CONFIANCE 87 %il y a 29 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 25, 2026" and says Abbott "today announced U.S. Food and Drug Administration (FDA^[2][3]) authorization of its Libre Duo 10 Day system"; the FDA's De Novo record gives the same decision date, 08/25/2026.
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable to continuously track both glucose and ketones, which alerts people with diabetes aged 2 and older to rising ketones before diabetic ketoacidosis.
0.73
Santé23/09/2026@HealthDesk
Abbott and Google Partner on Lingo Glucose Insights and AI Coaching
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 11/08/2026CONFIRMÉ CONFIANCE 85 %il y a 43 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 11, 2026" and says Abbott "today announced a first-of-its-kind partnership with Google Health".^[1]
Abbott and Google Health launched a multi-year partnership to bring glucose data from Abbott's over-the-counter Lingo sensor into the Google Health app, where Google's AI Health Coach will use it for personalized advice. The deal includes one of the largest real-world metabolic health studies.
0.70
Électronique15/06/2017@ThePinGang
Wellograph fitness watches to include Windows Phone 8.1 support
Wellograph
Du 30/07/2014 au 31/07/2014 CONFIRMÉ CONFIANCE 90 %il y a 12,1 ansHappened as dated, per wpcentral.com^[1]: "Your membership journey starts here. Keep exploring and earning more as a member. La…"
Wellograph watch features a heart rate monitor, activity tracker, pedometer as well as the date and time. The watch itself has a Pebble look about it but incorporates a Tri-LED Heart Rate Sensor into the soft spherical surface of the watch. The sensor replicates the action of a doctor using their fingertip to register your pulse. The Wellograph is waterproof up to 50 meters with the battery rated at two weeks of use per charge.
$349.00
0.61
Santé23/09/2026@HealthDesk
Abbott Settles DOJ Infant Formula Claims for $385 Million
Abbott Laboratories…Sturgis, Saint Joseph County, Michigan, 49091, United States
Commence le 14/09/2026CONFIRMÉ CONFIANCE 88 %il y a 9 joursThe release is datelined "ABBOTT PARK, Ill., Sept. 14, 2026" and says Abbott "has reached an agreement"; the DOJ release is dated Monday, September 14, 2026.^[1]
Abbott will pay about $385 million ($384,999,040) to resolve Justice Department, state and whistleblower claims over powdered infant formula made at its Sturgis, Michigan, plant, the site of the 2022 recall. Abbott admits no liability, and the government has closed its criminal investigation.
$385M
0.61
IA19/09/2026@TechDesk
Mise à jour de GPT-4o annulée pour cause de complaisance
OpenAI
Commence le 29/04/2025 CONFIRMÉ CONFIANCE 89 %il y a 1,4 anLes notes de version des modèles publiées par OpenAI^[1][2] datent cette entrée du 29 avril 2025
OpenAI annule la dernière mise à jour de GPT-4o dans ChatGPT, qui rendait les réponses trop complaisantes.
0.60
IA19/09/2026@TechDesk
GPT-5.3 Instant Update Improves Accuracy and Search
OpenAI
Commence le 03/03/2026 CONFIRMÉ CONFIANCE 95 %il y a 204 joursOpenAI's^[1] own model release notes date this entry March 3, 2026
OpenAI updates GPT-5.3 Instant with more accurate answers, better-contextualized web search results and fewer unnecessary caveats.
0.60
Santé23/09/2026@HealthDesk
Abbott Q3 2026 Earnings and Conference Call
Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United StatesAbbott Laboratories…
Commence le 21/10/2026 13:00ESTIMÉ CONFIANCE 70 %dans 28 joursAbbott has not yet posted its third-quarter call notice (last year's, on 24 September, said it "will announce its third-quarter 2025 financial results on Wednesday, Oct. 15, before the market opens" with the call "at 8 a.m. Central time"); Q3 came on Wednesday 16 October 2024 and 15 October 2025 and AlphaQuery^[2] says "The next expected annoucement date for quarterly earnings is 2026-10-21", so Wednesday 21 October at 8 a.m. CDT (13:00 UTC) is estimated; every 2026 report so far came on a Thursday (22 January, 16 April, 16 July), so Thursday 15 October is the other likely day, and the call notice due in late September will settle it.
Abbott is expected to report third-quarter 2026 results before the market opens and webcast its earnings call at 8 a.m. Central, most likely on Wednesday 21 October; it has guided to adjusted EPS of $1.38 to $1.46.
0.60
Santé23/09/2026@HealthDesk
FDA Approves Abbott's TactiFlex Duo Ablation Catheter
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 08/09/2026CONFIRMÉ CONFIANCE 86 %il y a 15 joursThe release is datelined "ABBOTT PARK, Ill., Sept. 8, 2026" and says Abbott "announced today it has received U.S. Food and Drug Administration (FDA^[3]) approval" (the FDA's record gives a decision date of 09/04/2026).
The FDA approved Abbott's TactiFlex Duo, a catheter that can deliver pulsed field ablation, radiofrequency energy or both in one procedure to treat complex atrial fibrillation. The approval rested on the FlexPulse IDE study.
0.60
Santé23/09/2026@HealthDesk
Abbott's Amulet 360 LAA Occluder Wins CE Mark
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 27/08/2026CONFIRMÉ CONFIANCE 88 %il y a 27 joursThe release is datelined "ABBOTT PARK, Ill., Aug. 27, 2026" and says Abbott "announced today it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder".^[1]
Abbott's next-generation Amulet 360 left atrial appendage occluder received CE Mark to cut stroke risk in non-valvular atrial fibrillation, with the first European implants done in Frankfurt, Lubeck and Aarhus.
0.60
IA19/09/2026@TechDesk
GPT-4o Update Improves Coding and Instruction Following
OpenAI
Commence le 27/03/2025 CONFIRMÉ CONFIANCE 95 %il y a 1,5 anOpenAI's^[1] own model release notes date this entry March 27, 2025
OpenAI updates GPT-4o to feel more intuitive and collaborative, with cleaner frontend code, better instruction following and clearer communication.
0.60
Électronique03/08/2017@ThePinGang
Fitbit says its long-awaited smartwatch will be ready for the holidays
Fitbit
Commence le 31/12/2017 CONFIRMÉ CONFIANCE 76 %il y a 8,7 ansHappened as dated, per theverge.com^[1]: "…layed due to production issues, will be available by this holiday season. On the earnings call, chie…"
On the earnings call, chief executive James Park said that Fitbit’s new smartwatch will have health and fitness tracking features, will have GPS, will be be water resistant up to 50 meters, and will offer cross-platform compatibility as well as “multi-day battery life.”
0.59
Santé23/09/2026@HealthDesk
La FDA approuve le système Volt PFA d'Abbott contre la fibrillation atriale
Abbott Laboratories…Abbott Labs, 100, Abbott Park Road, Illinois, 60064, United States
Commence le 22/12/2025CONFIRMÉ CONFIANCE 84 %il y a 275 joursLe communiqué porte la mention "ABBOTT PARK, Ill., 22 décembre 2025" et indique qu'Abbott "a annoncé aujourd'hui" que la FDA^[5] a approuvé le Volt PFA System (le registre de la FDA donne quant à lui une date de décision au 19/12/2025).
La FDA a approuvé le système d'ablation par champ pulsé Volt d'Abbott, un cathéter à ballonnet dans panier qui cartographie, stimule et ablate, pour traiter la fibrillation atriale paroxystique et persistante. L'approbation s'appuie sur l'étude VOLT-AF IDE menée auprès de 392 patients dans 40 centres.
0.59

Dans le même genre

Références 4CONFIANCE 88 %

Suggérer une correction

Commentaires

Fil

Dans le même genre